Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 01-2003 | 12-2002 | 10-2002 | 09-2002 | 07-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,006 | -7,424 | 599 | -6,013 | 116 |
| Depreciation Amortization | 903 | 297 | 558 | 150 | 357 |
| Income taxes - deferred | -231 | N/A | -225 | N/A | -44 |
| Accounts receivable | -560 | -1,293 | -876 | -4 | 294 |
| Accounts payable and accrued liabilities | 175 | -67 | 511 | -190 | 99 |
| Other Working Capital | -2,053 | -884 | -1,418 | 54 | -360 |
| Other Operating Activity | 853 | 2,962 | 488 | 1,076 | -381 |
| Operating Cash Flow | $93 | $-6,409 | $-363 | $-4,927 | $81 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -520 | N/A | -837 | N/A |
| PPE Investments | -681 | N/A | -479 | N/A | -313 |
| Sale Of Investment | N/A | 5,293 | N/A | 5,310 | N/A |
| Purchase Sale Intangibles | N/A | -176 | N/A | -143 | N/A |
| Other Investing Activity | 0 | -176 | 0 | -143 | 0 |
| Investing Cash Flow | $-681 | $4,597 | $-479 | $4,330 | $-313 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 250 | N/A | N/A |
| Debt Repayment | -707 | N/A | -686 | N/A | -522 |
| Common Stock Issued | N/A | 65 | N/A | 65 | N/A |
| Common Stock Repurchased | -150 | -50 | -41 | -50 | -95 |
| Other Financing Activity | 0 | 946 | 0 | 946 | 0 |
| Financing Cash Flow | $-857 | $961 | $-477 | $961 | $-617 |
| Beginning Cash Position | 1,705 | 3,107 | 1,705 | 3,107 | 1,705 |
| End Cash Position | 260 | 2,256 | 386 | 3,471 | 856 |
| Net Cash Flow | $-1,445 | $-851 | $-1,319 | $364 | $-849 |
| Free Cash Flow | |||||
| Operating Cash Flow | 93 | -6,409 | -363 | -4,927 | 81 |
| Capital Expenditure | -681 | N/A | -479 | N/A | -313 |
| Free Cash Flow | -588 | -6,409 | -842 | -4,927 | -232 |